T0	Participants 64 90	autism spectrum disorders.
T1	Participants 302 335	in brains of patients with autism
T2	Participants 447 459	exploration.
T3	Participants 460 520	Twenty children with autism spectrum disorder age 4-12 years
T4	Participants 808 886	RESULTS Eighteen participants (10 mecamylamine, 8 placebo) completed the study